Inventor · disambiguated record
Lu Gao
Also filed as: GAO LU
16 granted patents·9 pending applications·51 citations·filing 2012–2023
90Inventor score
Files withHOFFMANN LA ROCHE21CHEN LI1JIANGSU HENGRUI PHARMACEUTICALS CO LTD1SHANGHAI REGENELEAD THERAPIES CO LTD1SHI JUMEI1
Top patents by PatentIndex Score
25 records- 0192US10618929B23-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Apr 14, 2020·5 cites·22 claims
- 0292US10596173B2Combination therapy of an HBV capsid assembly inhibitor and an interferonHOFFMANN LA ROCHE·Filed 2018·Granted Mar 24, 2020·10 cites·25 claims
- 0392US10233184B27-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Mar 19, 2019·12 cites·31 claims
- 0492US9441008B23-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Sep 13, 2016·13 cites·54 claims
- 0589US10040815B23-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Aug 7, 2018·7 cites·18 claims
- 0679US8871756B2Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus diseaseCHEN LI·Filed 2012·Granted Oct 28, 2014·4 cites·56 claims
- 0766US11180525B2Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infectionHOFFMANN LA ROCHE·Filed 2020·Granted Nov 23, 2021·0 cites·12 claims
- 0866US10752630B27-substituted sulfonimidoylpurinone compounds for the treatment of virus infectionHOFFMANN LA ROCHE·Filed 2019·Granted Aug 25, 2020·0 cites·22 claims
- 0965US2020385387A17-substituted sulfonimidoylpurinone compounds for the treatment of virus infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1061USRE49481ECompounds for the treatment and prophylaxis of respiratory syncytial virus diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Apr 4, 2023·0 cites·59 claims
- 1159US2023119360A1Pharmaceutical combination of a therapeutic oligonucleotide targeting hbv and a tlr7 agonist for treatment of hbvHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1259US2025288659A1Nucleic acid construct and use thereofSHANGHAI REGENELEAD THERAPIES CO LTD·Filed 2023·Application pending·0 cites
- 1356US2020276198A1Combination therapy of an hbv capsid assembly inhibitor and an interferonHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1449US10611748B2Xanthone derivatives for the treatment of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Apr 7, 2020·0 cites·31 claims
- 1549US2025188091A1Pyridone compound having integrase inhibitory activity and pharmaceutical use thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1647US2022370447A1Method of treating hbv infection using a core protein allosteric modulatorHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1746US11337982B2Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitorHOFFMANN LA ROCHE·Filed 2019·Granted May 24, 2022·0 cites·14 claims
- 1845US9670211B2Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Jun 6, 2017·0 cites·10 claims
- 1945US2017327797A1Recombinant hbv cccdna, the method to generate thereof and the use thereofHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2040US11771699B2Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitorHOFFMANN LA ROCHE·Filed 2017·Granted Oct 3, 2023·0 cites·32 claims
- 2140US9790213B2Imidazoles for the treatment and prophylaxis of respiratory syncytial virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Oct 17, 2017·0 cites·8 claims
- 2238US9206191B2Indazoles for the treatment and prophylaxis of respiratory syncytial virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Dec 8, 2015·0 cites·25 claims
- 2336US10189838B2Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Jan 29, 2019·0 cites·11 claims
- 2436US2019060330A1Application of 4-hydroxy salicylanilide in preparation of anti-myeloma or anti-lymphoma drugsSHI JUMEI·Filed 2016·Application pending·0 cites
- 2532US2016200741A1Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infectionHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lu Gao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →